Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
SYNERGISTIC EFFECTS OF NUCLEAR TRANSCRIPTION FACTOR NF-kappaB INHIBITORS AND ANTI-NEOPLASTIC AGENTS
Document Type and Number:
WIPO Patent Application WO2003090681
Kind Code:
A3
Abstract:
The present invention provides methods of inhibiting metastasis of a tumor and methods of treating a tumor using a combination of an inhibitor of the activation of nuclear factor NF-kappaB and a cancer chemotherapeutic agent. In one embodiment of the present invention, combination of curcumin and paclitaxel (taxol) can be used to treat and inhibit metastasis of breast tumor.

Inventors:
AGGARWAL BHARAT
Application Number:
PCT/US2003/012617
Publication Date:
August 26, 2004
Filing Date:
April 24, 2003
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
RES DEV FOUNDATION (US)
International Classes:
A61K45/06; A61K31/05; A61K31/12; A61K31/16; A61K31/337; A61K31/44; A61K31/454; A61K31/525; A61P35/04; A61P43/00; (IPC1-7): A61K31/12; A61K31/44
Other References:
DATABASE CAPLUS [online] ICHIKI ET AL: "Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer", XP003019059, Database accession no. 2001:871165
DATABASE CAPLUS [online] JAFFE ET AL: "Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma", XP003019060, Database accession no. 1975:51753
DATABASE CAPLUS [online] MENON ET AL: "Anti-metastatic activity of cucurmin and catechin", XP003019064, Database accession no. 1999:360049
DATABASE CAPLUS [online] SRIGANTH ET AL: "Dietary curcumin with cisplatin administration modulates tumor marker indices in experimental fibrosarcoma", XP003019061, Database accession no. 1999:248004
DATABASE CAPLUS [online] HOUR ET AL: "Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21WAF1/CIP1 and C/EBP.bet.xpressions and supressing NF-.kappa.B activation", XP003019062, Database accession no. 2002:420392
See also references of EP 1496880A4
Download PDF: